DuPont (DD)
NYSE: DD · Specialty Chemicals · Wilmington, DE
Our rating: Cautious
Cautious reaffirmed at $150.73, moderate conviction, November 4, 2026.
Breaks if: The cautious view is wrong if DuPont reports positive GAAP net income in each of the next two consecutive quarterly filings (through roughly mid-FY2027), confirming the charges driving the current $779M net loss were one-time and are now cleared. It would also be invalidated if year-on-year revenue growth accelerates to 5% or more in two successive quarters within the next 12 months, demonstrating that volume momentum has returned. The call deepens in the other direction if free cash flow falls below $350M over the next four reported quarters, or if the reported net loss widens beyond $1.0B.
Key figures
| Market value | $19.3B |
|---|---|
| Revenue, last 12 months | $7.1B |
| Net income, last 12 months | $301M |
| Free cash flow, last 12 months | n/a |
| Price to earnings | 64.0× |
| Free cash flow yield | n/a |
| Dividend yield | 2.6% |
| Operating margin | n/a |
| Return on equity | 1.7% |
| Beta to the S&P 500 | 1.16 |
| Volatility, annualized | 30.8% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.9B | 4.1% | $0.91 | n/a |
| June 30, 2026 | $1.8B | 4.0% | $1.05 | n/a |
| March 31, 2026 | $1.7B | 4.3% | $0.39 | n/a |
| December 31, 2025 | $1.7B | 0.2% | $-0.30 | n/a |
| September 30, 2025 | $1.8B | 4.7% | $-0.88 | n/a |
| June 30, 2025 | $1.7B | 1.9% | $0.42 | n/a |
| March 31, 2025 | $1.6B | 0.8% | $-1.40 | n/a |
| December 31, 2024 | $1.7B | −166.1% | $-0.28 | n/a |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.75B: Claude 72%, Gemini 90%, Mistral 70%
- Diluted earnings per share are above zero: Claude 62%, Gemini 85%, Mistral 68%
14 ledger entries and 45 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.